Advertisement
Canada markets closed
  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CAD/USD

    0.7257
    -0.0006 (-0.09%)
     
  • CRUDE OIL

    84.20
    +1.47 (+1.78%)
     
  • Bitcoin CAD

    85,596.72
    +918.75 (+1.09%)
     
  • CMC Crypto 200

    1,295.42
    +409.88 (+46.29%)
     
  • GOLD FUTURES

    2,404.50
    +6.50 (+0.27%)
     
  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     
  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     
  • NASDAQ futures

    17,404.00
    -143.25 (-0.82%)
     
  • VOLATILITY

    18.00
    -0.21 (-1.15%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • NIKKEI 225

    37,290.07
    -789.63 (-2.07%)
     
  • CAD/EUR

    0.6822
    +0.0001 (+0.01%)
     

The Arvinas, Inc. (NASDAQ:ARVN) Analysts Have Been Trimming Their Sales Forecasts

The analysts covering Arvinas, Inc. (NASDAQ:ARVN) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. Revenue estimates were cut sharply as analysts signalled a weaker outlook - perhaps a sign that investors should temper their expectations as well. The stock price has risen 8.1% to US$41.09 over the past week. We'd be curious to see if the downgrade is enough to reverse investor sentiment on the business.

Following the latest downgrade, the current consensus, from the seven analysts covering Arvinas, is for revenues of US$21m in 2020, which would reflect a substantial 50% reduction in Arvinas' sales over the past 12 months. Losses are supposed to balloon 20% to US$2.57 per share. However, before this estimates update, the consensus had been expecting revenues of US$25m and US$2.35 per share in losses. So there's been quite a change-up of views after the recent consensus updates, with the analysts making a serious cut to their revenue forecasts while also expecting losses per share to increase.

Check out our latest analysis for Arvinas

NasdaqGS:ARVN Past and Future Earnings March 31st 2020
NasdaqGS:ARVN Past and Future Earnings March 31st 2020

Of course, another way to look at these forecasts is to place them into context against the industry itself. We would highlight that sales are expected to reverse, with the forecast 50% revenue decline a notable change from historical growth of 64% over the last three years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 5.1% next year. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - Arvinas is expected to lag the wider industry.

The Bottom Line

The most important thing to take away is that analysts increased their loss per share estimates for this year. Unfortunately analysts also downgraded their revenue estimates, and industry data suggests that Arvinas' revenues are expected to grow slower than the wider market. Often, one downgrade can set off a daisy-chain of cuts, especially if an industry is in decline. So we wouldn't be surprised if the market became a lot more cautious on Arvinas after today.

ADVERTISEMENT

After a downgrade like this, it's pretty clear that previous forecasts were too optimistic. What's more, we've spotted several possible issues with Arvinas' business, like recent substantial insider selling. Learn more, and discover the 3 other risks we've identified, for free on our platform here.

Of course, seeing company management invest large sums of money in a stock can be just as useful as knowing whether analysts are downgrading their estimates. So you may also wish to search this free list of stocks that insiders are buying.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.